GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS

Details for Australian Patent Application No. 2002352483 (hide)

Owner SMITHKLINE BEECHAM P.L.C.

Inventors COULTON, Steven; HADLEY, Michael, Stewart; HERDON, Hugh, Jonathan; JIN, Jian; JOINER, Graham, J; PORTER, Roderick, Alan; RAHMAN, Shahzad, Sharooq

Pub. Number AU-A-2002352483

PCT Number PCT/GB02/05819

PCT Pub. Number WO2003/055478

Priority 0130696.8 21.12.01 GB

Filing date 19 December 2002

Wipo publication date 15 July 2003

International Classifications

A61K 031/33 - Heterocyclic compounds

C07D 207/06 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/44 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/06 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 223/04 Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 333/34 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 311/70 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 285/14 Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 271/12 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 333/62 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61P 025/18 Drugs for disorders of the nervous system

A61P 025/28 Drugs for disorders of the nervous system

C07D 295/12 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 0130696.8 21.12.01 GB

4 September 2003 Application Open to Public Inspection

  Published as AU-A-2002352483

9 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352484-A METHOD OF AND APPARATUS FOR PROCESSING SEISMIC DATA IN THE PRESENCE OF ANISOTROPY

2002352482-DNA CONSTRUCT AND METHOD FOR INCREASING PRODUCTION OF VITAMIN C IN A PLANT